Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial

NCT02066311 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT02066311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial
Lead sponsor
Northwell Health
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2014
Completion date
June 30, 2018
Enrollment
15 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus